Results 81 to 90 of about 402 (126)

P-110 Soluble St2 [PDF]

Inflammatory Bowel Diseases, 2014
Quera Rodrigo, Diaz-Jimenez David, Simian Daniela, De La Fuente Marjorie, Landskron Glauben, Garcia Paulina, Dubois Karen, Fuentes Janitza, Perez Tamara, Hermoso Marcela   +9 more
openaire   +1 more source

Prognostic Value of Baseline and Soluble ST2 Change in Patients With Light Chain Cardiac Amyloidosis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The prognostic significance of dynamic changes in soluble suppression of tumorigenicity‐2 (sST2) in patients with light chain cardiac amyloidosis (AL‐CA) remains unclear.
Anran Xin, Xinqing Li, Yan Huang, Qiong Zhou, Xiaofeng Zhuang, Huihui Liu, Ping Zhou, Jinxi Wang, Xuemei Zhao, Jian Zhang, Yuhui Zhang   +10 more
doaj   +1 more source

Relationship between serum soluble suppression of tumorigenicity (ST) 2 and global longitudinal strain in early onset preeclampsia

BMC Cardiovascular Disorders
Background Preeclampsia is one of the leading causes of death in childbearing women worldwide. Hemodynamic changes in preeclampsia can trigger cardiac remodeling as indicated by increase of soluble-ST2 (sST2).
Hawani Sasmaya Prameswari, Cut Azlina Effendi, Achmad Fitrah Khalid, Setyorini Irianti, Ita Fatati, Mohammad Rizki Akbar   +5 more
doaj   +1 more source

Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States

Diabetes, Metabolic Syndrome and Obesity, 2020
Amal Hasan,1 Shihab Kochumon,1 Ebaa Al-Ozairi,2,3 Jaakko Tuomilehto,4– 6 Fahd Al-Mulla,7 Rasheed Ahmad1 1Department of Immunology and Microbiology, Dasman Diabetes Institute, Kuwait City, Kuwait; 2Clinical Research Unit, Medical Division, Dasman ...
Hasan A, Kochumon S, Al-Ozairi E, Tuomilehto J, Al-Mulla F, Ahmad R   +5 more
doaj  

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Serum Soluble ST2

Journal of the American College of Cardiology, 2010
Weir, Robin A.P., Miller, Ashley M., Murphy, Grace E.J., Clements, Suzanne, Steedman, Tracey, Connell, John M.C., McInnes, Iain B., Dargie, Henry J., McMurray, John J.V.   +8 more
openaire   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Is soluble ST2 a new marker in heart failure?

, 2018
The clinical diagnosis of heart failure (HF) is based on a history and a physical examination. Circulating molecules, suchas troponin, B-type natriuretic peptide, and N-terminal pro-B-type natriuretic peptide are useful in the management ofHF. Recently, it has been reported that a new biomarker, suppression of tumorigenicity (ST2), was associated with ...
openaire   +1 more source

Soluble ST2 for Prognosis and Monitoring in Heart Failure

Journal of the American College of Cardiology, 2017
Antoni Bayés-Genís, Julio Núñez, Josep Lupón   +2 more
openaire   +1 more source